% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Schroeder:120666,
author = {L. Schroeder$^*$ and P. Boscolo-Rizzo and E. Dal Cin and S.
Romeo and L. Baboci$^*$ and G. Dyckhoff and J. Hess$^*$ and
C. Lucena-Porcel and A. Byl and N. Becker and L. Alemany and
X. Castellsagué and M. Quer and X. León and M.
Wiesenfarth$^*$ and M. Pawlita$^*$ and D. Holzinger$^*$},
title = {{H}uman papillomavirus as prognostic marker with rising
prevalence in neck squamous cell carcinoma of unknown
primary: {A} retrospective multicentre study.},
journal = {European journal of cancer},
volume = {74},
issn = {0959-8049},
address = {Amsterdam [u.a.]},
publisher = {Elsevier},
reportid = {DKFZ-2017-01092},
pages = {73 - 81},
year = {2017},
abstract = {Patients with neck squamous cell carcinomas of unknown
primary tumour (NSCCUP) present with lymph node metastasis
without evidence for a primary tumour. Most patients undergo
an aggressive multimodal treatment, which induces severe,
potentially unnecessary toxicity. Primary tumours of NSCCUP
can be hidden in the oropharynx. Human papillomavirus (HPV)
is causally involved in a subgroup of oropharyngeal squamous
cell carcinomas (OPSCC) associated with early lymph node
metastasis and good prognosis. Detection of markers for HPV
transformation in NSCCUP could allow focussing on the
oropharynx in primary tumour search and could be of value
for choice and extent of treatment. In a retrospective
multicentre study (Germany, Italy and Spain), we analysed
metastatic lymph nodes from 180 NSCCUP patients for the
presence of HPV DNA, HPV E6*I mRNA and cellular p16(INK4a)
overexpression, a surrogate marker for HPV-induced
transformation. HPV status, defined as positivity for viral
mRNA with at least one additional marker, was correlated
with clinical parameters and survival outcome. A substantial
proportion $(16\%)$ of NSCCUP were HPV-driven, mainly by
HPV16 $(89\%).$ HPV prevalence increased with year of
diagnosis from $9\%$ during 1998-2004 to $23\%$ during
2005-2014 (p = 0.007). HPV-driven NSCCUP had significantly
better overall and progression-free survival rates
(p ≤ 0.008). Based on this survival benefit, it is
contended that HPV RNA status should be included in NSCCUP
diagnosis and in therapeutic decision-making.
Deintensification of radiation in patients with HPV-driven
NSCCUP, while concurrently concentrating on the oropharynx
appears to be a promising therapeutic strategy, the efficacy
of which should be assessed in prospective trials. To our
knowledge, this is the largest study on HPV in NSCCUP.},
cin = {F020 / G405 / C060},
ddc = {610},
cid = {I:(DE-He78)F020-20160331 / I:(DE-He78)G405-20160331 /
I:(DE-He78)C060-20160331},
pnm = {316 - Infections and cancer (POF3-316)},
pid = {G:(DE-HGF)POF3-316},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:28335889},
doi = {10.1016/j.ejca.2016.12.020},
url = {https://inrepo02.dkfz.de/record/120666},
}